Psilocybin Shows Promise for Long COVID Symptoms in New Study
Millions of people continue to struggle with long COVID. Now, new research suggests psilocybin mushrooms may offer relief.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
Millions of people continue to struggle with long COVID. Now, new research suggests psilocybin mushrooms may offer relief.
Read More
The Department of Justice failed to meet a January 16 deadline to publish new rules simplifying Schedule I research.
Read More
Researchers found that small doses of psilocybin can improve the originality, but not the amount, of creative ideas.
Read More
Psilocybin has shown promise for treating depression, but its hallucinogenic effects create barriers. A new study may change that.
Read More
This FDA decision represents meaningful progress. A new option may finally be on the horizon for those suffering PTSD.
Read More
The findings add to growing evidence that psychedelics may treat conditions long resistant to conventional approaches.
Read More
State health officials announced plans to launch the medical psilocybin program by December 2026. That is a full year ahead of schedule.
Read More
Knowing which members of Congress will advance or block psychedelic medicine helps advocates know where to focus their energy.
Read More
The Freedom to Heal Act would allow doctors to legally administer Schedule I drugs like MDMA and psilocybin to very ill patients.
Read More
Three healing centers now offer supervised psychedelic mushroom sessions in the Boulder and mark a milestone in CO's natural medicine program.
Read More